June 4, 2010 — Novavax, Inc. has appointed Mark O. Thornton, MD, MPH, PhD, as the company's senior vice president, development and chief medical officer. Dr. Thornton previously served as a medical officer in the US Navy and the US Food and Drug Administration's (FDA) immunology and infectious diseases branch and division of therapeutic biologic oncology products, chief medical officer of ZioPharm Oncology, Inc., managing director of clinical and regulatory affairs at Angiotech Pharmaceuticals, Inc. and, most recently, senior vice president of product development at GenVec, Inc. He has also previously served as director of clinical research at Otsuka America Pharmaceutical, Inc. and North American Vaccine Co. and associate director of clinical research at Univax Biologics, Inc. Thornton is a member of the Johns Hopkins Medical and Surgical Society, the American Society for Microbiology, the Infectious Disease Society of America and the American Society of Clinical Oncology. Novavax, Inc. is a clinical-stage biopharmaceutical company based in Rockville.
| Visionary: The Odyssey of Sir Arthur C. Clarke April 2, 2012 - Visionary offers the first full-life chronicle of the man whose fiction, including his groundbreaking collaboration with Stanley Kubrick on the film "2001," has received all of science fiction’s highest awards, and whose visionary contribution to science has earned him the nickname, "Godfather of the Communication Satellite." Read more at The British Interplanetary Society... |
 |
 |
 |
|
||
 |
|
 |
|
||
|
|
| DBED's Cybersecurity Blog |
| Corridor Inc.’s Strategic Partners |
| CENTER MARYLAND |
| PRESSBOX |
| GREATER BALTIMORE COMMITTEE |
